Literature DB >> 7648647

Nifedipine in ischemic heart disease.

R A Kloner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648647     DOI: 10.1161/01.cir.92.5.1074

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  The prevention of cardiovascular events. A new challenge for calcium channel blockers. Introduction.

Authors:  K I Lie
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Controversies concerning calcium antagonists.

Authors:  P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Calcium channel blocker debate: true lies?

Authors:  J Leor; A Battler
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 4.  Meta-analyses of antihypertensive therapy: Are some of them misleading?

Authors:  E Grossman; U Goldbourt
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 5.  Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers?

Authors:  W E Boden
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 6.  Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.

Authors:  H D Langtry; C M Spencer
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 7.  Calcium antagonists during and after myocardial infarction.

Authors:  P Sleight
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy.

Authors:  Carl Plumley; Eric M Gorman; Nashwa El-Gendy; Connor R Bybee; Eric J Munson; Cory Berkland
Journal:  Int J Pharm       Date:  2008-10-25       Impact factor: 5.875

Review 10.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.